See other bills
under the
same topic
                                                      PRINTER'S NO. 1154

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 979 Session of 2003


        INTRODUCED BY MICOZZIE, KENNEY, BUXTON, HENNESSEY, MELIO,
           BELARDI, BUNT, CAPPELLI, CREIGHTON, CURRY, DeWEESE, FLEAGLE,
           GEIST, HARHAI, LaGROTTA, McILHATTAN, NAILOR, SHANER, SOLOBAY,
           STERN, E. Z. TAYLOR, WASHINGTON AND YOUNGBLOOD,
           MARCH 26, 2003

        REFERRED TO COMMITTEE ON INSURANCE, MARCH 26, 2003

                                     AN ACT

     1  Amending the act of December 20, 1996 (P.L.1492, No.191),
     2     entitled "An act providing for certain health insurance
     3     policies to cover the cost of formulas necessary for the
     4     treatment of phenylketonuria and related disorders," further
     5     defining "health insurance policy"; and providing for low-
     6     protein modified food products.

     7     The General Assembly of the Commonwealth of Pennsylvania
     8  hereby enacts as follows:
     9     Section 1.  Sections 2, 3, 4, 6 and 7 of the act of December
    10  20, 1996 (P.L.1492, No.191), known as the Medical Foods
    11  Insurance Coverage Act, are amended to read:
    12  Section 2.  Declaration of policy.
    13     The General Assembly finds and declares as follows:
    14         (1)  Phenylketonuria (PKU), branched-chain ketonuria,
    15     galactosemia and homocystinuria are aminoacidopathies that
    16     are rare hereditary genetic metabolic disorders.
    17         (2)  Lacking in these aminoacidopathies is the body's
    18     ability to process or metabolize amino acids, and, if left


     1     untreated or without proper therapeutic management, these
     2     disorders cause severe mental retardation and chronic
     3     physical disabilities.
     4         (3)  The only form of treatment is by restricting food
     5     intake in order to remove the problem amino acids, which are
     6     necessary in the diet, and then replenishing them in
     7     carefully controlled measured amounts of a nutritional food
     8     substitute.
     9         (4)  In an attempt to encourage the development of new
    10     products, increase availability and reduce cost, formulas
    11     were removed from the Federal prescription list and
    12     reclassified as medical foods. An unfortunate side effect has
    13     been the reluctance of many insurance companies to cover the
    14     cost of these formulas. In instances where coverage is
    15     provided, it is random and subject to inconsistent
    16     interpretation.
    17         (5)  The intent of this legislation is not to require
    18     insurance coverage for [normal food products] natural food
    19     products that are naturally low in protein which are used in
    20     dietary management of these disorders, but to provide for
    21     such coverage of formulas that are equivalent to a
    22     prescription drug and low-protein modified food products
    23     medically necessary for the therapeutic treatment of such
    24     rare hereditary genetic metabolic disorders and administered
    25     under the direction of a physician.
    26         (6)  In recognition by the General Assembly that such
    27     formulas and low-protein modified food products are medically
    28     necessary and critical to the well-being of individuals
    29     afflicted with rare hereditary genetic metabolic disorders,
    30     it shall be required that health insurance policies issued in
    20030H0979B1154                  - 2 -     

     1     this Commonwealth shall include such coverage.
     2  Section 3.  Definitions.
     3     The following words and phrases when used in this act shall
     4  have the meanings given to them in this section unless the
     5  context clearly indicates otherwise:
     6     "Health insurance policy."  Except for specified disease and
     7  accident-only policies, the term shall mean any group health
     8  insurance policy, contract or plan or any individual policy,
     9  contract or plan [with coverage for prescription drugs] which
    10  provides medical coverage on an expense-incurred, service or
    11  prepaid basis. The term includes the following:
    12         (1)  A health insurance policy or contract issued by a
    13     nonprofit corporation subject to 40 Pa.C.S. Chs. 61 (relating
    14     to hospital plan corporations) and 63 (relating to
    15     professional health services plan corporations) and [the act
    16     of December 14, 1992 (P.L.835, No.134), known as the
    17     Fraternal Benefit Societies Code.] Article 24 of the act of
    18     May 17, 1921 (P.L.582, No.294), known as The Insurance
    19     Company Law of 1921.
    20         (2)  A health service plan operating under the act of
    21     December 29, 1972 (P.L.1701, No.364), known as the Health
    22     Maintenance Organization Act.
    23     "Low-protein modified food product."  A food product that is
    24  specially formulated to have less than one gram of protein per
    25  serving, and intended to be administered by and used under the
    26  direction of a physician for the therapeutic and dietary
    27  treatment of phenylketonuria, branched-chain ketonuria,
    28  galactosemia and homocystinuria. The term does not include a
    29  natural food that is naturally low in protein.
    30  Section 4.  Medical foods insurance coverage.
    20030H0979B1154                  - 3 -     

     1     (a)  General rule.--Except as provided in section 7, any
     2  health insurance policy which is delivered, issued for delivery,
     3  renewed, extended or modified in this Commonwealth by any health
     4  care insurer shall provide that the health insurance benefits
     5  applicable under the policy include coverage for the cost of
     6  nutritional supplements (formulas) and low-protein modified food
     7  products as medically necessary for the therapeutic treatment of
     8  phenylketonuria, branched-chain ketonuria, galactosemia and
     9  homocystinuria as administered under the direction of a
    10  physician. Coverage for low-protein modified food products for
    11  the treatment of phenylketonuria, branched-chain ketonuria,
    12  galactosemia and homocystinuria for any calendar year or for any
    13  continuous period of 12 months shall not exceed $2,500 for an
    14  insured individual subject to adjustment as provided in
    15  subsection (b).
    16     (b)  Adjustment of cap.--
    17         (1)  The Insurance Department, at least once every three
    18     years, shall adjust the $2,500 cap or limit relative set
    19     forth in subsection (a) to changes in the components of the
    20     Consumer Price Index (Urban) to measure seasonally adjusted
    21     changes in low protein modified food product costs and shall
    22     make such adjustments to the cap or limit as shall be
    23     necessary to maintain the same rate of change in the cap or
    24     limit as has occurred in the Consumer Price Index (Urban).
    25     Such adjustments may be rounded off to the nearest $50
    26     figure.
    27         (2)  The Insurance Department shall publish the
    28     adjustment as a notice in the Pennsylvania Bulletin.
    29  Section 6.  Cost-sharing provisions.
    30     (a)  Applicability.--Benefits for nutritional supplements
    20030H0979B1154                  - 4 -     

     1  (formulas) and low-protein modified food products as medically
     2  necessary for the therapeutic treatment of phenylketonuria,
     3  branched-chain ketonuria, galactosemia and homocystinuria as
     4  administered under the direction of a physician shall be subject
     5  to copayment and coinsurance provisions of a health insurance
     6  policy to the extent that other medical services covered by the
     7  policy are subject to those provisions.
     8     (b)  Exemption.--Benefits for nutritional supplements
     9  (formulas) and low-protein modified food products as medically
    10  necessary for the therapeutic treatment of phenylketonuria,
    11  branched-chain ketonuria, galactosemia and homocystinuria as
    12  administered under the direction of a physician shall be exempt
    13  from deductible provisions in a health insurance policy. This
    14  exemption must be explicitly provided for in the policy.
    15  Section 7.  Exemption.
    16     Notwithstanding sections 4 and 5, this act shall not be
    17  construed to require a health insurance policy to include
    18  coverage for nutritional supplements (formulas) and low-protein
    19  modified food products as medically necessary for the
    20  therapeutic treatment of phenylketonuria, branched-chain
    21  ketonuria, galactosemia and homocystinuria as administered under
    22  the direction of a physician for an individual who is a resident
    23  of this Commonwealth if all of the following apply:
    24         (1)  The individual is employed outside this
    25     Commonwealth.
    26         (2)  The individual's employer maintains a health
    27     insurance policy for the individual as an employment benefit.
    28     Section 2.  This act shall take effect in 180 days.


    A24L40SFL/20030H0979B1154        - 5 -